Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aratana debates future of stem cell candidate following study

Aratana Therapeutics must decide if it will continue the development of a treatment candidate for canine osteoarthritis after analyzing the results of a recent study. 

Aratana Therapeutics Canine Osteoarthritis

Dechra makes a small but significant acquisition in New Zealand

Dechra Pharmaceuticals has again returned to Australasia for its latest acquisition. 

New Zealand Companion Animals M&A

Adisseo acquires Nutriad as it builds on global presence

French animal feed additives specialist Adisseo has acquired Belgian firm Nutriad for an undisclosed amount. 

Europe Asia Pacific Belgium

Polish company to take bacteriophages to the global market

Developing a bacteriophage platform technology for use in animal health has taken Polish company Proteon Pharmaceuticals a decade to master. Chief operating officer Mathew Tebeau talks to Animal Pharm analyst Malcolm Flanagan about the firm's past and future.

Europe Poland Vaccines

Latest Articles

New leader at Norwegian salmon research center
Aratana debates future of stem cell candidate following study
Ireland edges toward BVD eradication in cattle
Zomedica wraps up 2017 with several milestone achievements for pipeline
European boost for Australian cannabis treatment firm
Genetic breakthrough in salmon pancreas disease
Animal Pharm M&A table 2017
Hendrix Genetics selects new CFO
Dechra makes a small but significant acquisition in New Zealand
Jaguar taps the Middle East equine market with key deal in Dubai
Cases of Salmonella in EU poultry on the rise
Animal Health Institute commits to One Health goal in the US
Le Vet bags decentralized approvals for dogs and cats in EU
Nominations for Animal Pharm Awards 2017 near deadline
Adisseo acquires Nutriad as it builds on global presence
Krka makes progress with marketing authorizations
ECO gets Canadian green light for Aivlosin
Arecor creates vaccine which can combat PPR, ECF
Zoetis bivalent vaccine for canine influenza launched
Benchmark upbeat over sea lice product trials
MWI increases its presence on the US east coast with purchase
Polish company to take bacteriophages to the global market
Zoetis swine vaccine given positive opinion in Europe
Pre-clinical study backs Panion's canine epilepsy treatment
New Cargill China factory aimed at piglet feed
Advertisement
Advertisement

Commercial

TechAccel: Animal health is an under-appreciated investor target

US agricultural investment firm TechAccel has underlined the need for more venture capital investment in animal health – music to the ears of many start-ups in the industry.

Investments Antiparasitics Diagnostics

Latest From Commercial

New leader at Norwegian salmon research center

Norway's leading innovative salmon research body, the Center for Closed Containment Aquaculture Systems (CtrlAQUA), has selected a new permanent director. 

People Aquaculture

Zomedica wraps up 2017 with several milestone achievements for pipeline

US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017. 

R&D Pharmaceuticals

European boost for Australian cannabis treatment firm

Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA). 

R&D Pain

Genetic breakthrough in salmon pancreas disease

Aquaculture scientists in Norway have found genetic markers that may lead to higher survival in salmon against pancreas disease (PD).

Research Aquaculture

Animal Pharm M&A table 2017

Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2017.

M&A Commercial

Hendrix Genetics selects new CFO

Dutch livestock breeding company Hendrix Genetics has selected a new chief financial officer (CFO).

People
See All

Top Interviews & Analysis

Dechra heads towards top 10 as pipeline signifies growing food animal influence

This year, Dechra Pharmaceuticals celebrated its 20th birthday. The previous two decades have seen the firm stimulate its turnover – and share price – with a combination of acquisitions and organic growth. Animal Pharm editor Joseph Harvey takes a look at what the coming years hold for the leading UK-based animal health company.

M&A R&D

Jobs ad

Products

Virbac's Nobivac LeuFel becomes first pet vaccine to get European approval this year

Virbac has secured the first centralized European marketing authorization for a companion animal vaccine in 2017.

Europe Vaccines Feline

Latest From Product

Zomedica wraps up 2017 with several milestone achievements for pipeline

US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017. 

R&D Pharmaceuticals

European boost for Australian cannabis treatment firm

Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA). 

R&D Pain

Le Vet bags decentralized approvals for dogs and cats in EU

Dutch firm Le Vet Pharma has received European approval for two generic companion animal products.

Europe Canine

Krka makes progress with marketing authorizations

Slovenian animal health company Krka said it has obtained marketing authorization for several new products in the first nine months of fiscal 2017.

Slovenia Europe

ECO gets Canadian green light for Aivlosin

UK company ECO Animal Health has received marketing authorization for its lead product Aivlosin in Canada.

North America United States

Arecor creates vaccine which can combat PPR, ECF

UK biopharmaceutical company Arecor has joined with Scottish animal health charity GALVmed to create a vaccine to combat two major diseases of livestock in the developing world.

Europe Middle East and Africa
See All

Sectors

US start-up gains exclusive licence for checkpoint inhibitor tech

Man's Best Friend Therapeutics (MBFT) has furthered its partnership with the Wistar Institute to develop immunotherapeutic vaccines for companion animals.

Vaccines Cancer Canine

Latest From Sector

Zomedica wraps up 2017 with several milestone achievements for pipeline

US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017. 

R&D Pharmaceuticals

European boost for Australian cannabis treatment firm

Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA). 

R&D Pain

Benchmark upbeat over sea lice product trials

US aquaculture health and genetics company Benchmark said commercial scale trials have proved a success for its sea lice treatment Ectosan.

Europe Norway

Leading EU expert on public health backs EPRUMA antibiotic initiatives

One of the European Parliament's leading advocates for improved public health in the EU has said understanding the effects of antibiotics in animal health is pivotal to making progress.

Europe European Commission

Oasmia to list veterinary assets on Nasdaq under AdvaVet

Swedish firm Oasmia Pharmaceuticals is aiming to list its veterinary assets on the Nasdaq through its wholly-owned US subsidiary. 

Companion Animals Operations

Sharp drop in US use of antibiotics in livestock

The US has seen the sale and distribution of antibiotics approved for use in food-producing animals in the country decrease by 10% from 2015 to 2016. 

FDA Pharmaceuticals

Latest From Policy & Regulation

Animal Health Institute commits to One Health goal in the US

US veterinary products industry body the Animal Health Institute (AHI) said it supports a judicious antibiotic use and is committed to a One Health policy in the country.

United States FDA

EU to move TSE laboratory to Italy after Brexit

The UK will no longer be home to the EU's reference laboratory for bovine spongiform encephalopathy (BSE) and other transmissible spongiform encephalopathies (TSEs) after Brexit, following a vote last month in Brussels.

United Kingdom Italy

Zoetis, Elanco and Hipra gain Canadian vaccine approvals

Zoetis has secured approval for two biologics in Canada, according to the latest update from the Canadian Food Inspection Agency (CFIA).

Canada Policy & Regulation

UK life sciences sector prioritizes Brexit goals for animal health

The Association of the British Pharmaceutical Industry (ABPI) has prioritized four goals in its approach to the UK's exit from the EU in March 2019.

Europe United Kingdom

Study highlights potential US export problems due to antibiotic usage rates

British food and farming lobby group Sustain said data from the FDA indicates antibiotic use in livestock in the US is twice the UK usage rate.

United States United Kingdom

Prospects for Australian animal health sector improve with new APVMA boss

After a turbulent year in the Australian animal health sector the appointment of Dr Chris Parker as chief executive of the Australian Pesticides and Veterinary Medicines Authority (APVMA) suggests a brighter future for the industry.

Australia APVMA
See All

Policy & Regulation

European regulatory focus shifts to Amsterdam with CVMP relocation

Amsterdam has marginally been chosen as the new location for the European Medicines Agency (EMA) and its Committee for Medicinal Products for Veterinary Use (CVMP).

Europe Netherlands Policy & Regulation
UsernamePublicRestriction

Register

Advertisement